Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Sevoflurane vs Propofol for Emergence Delirium and EEG in Preschool Ambulatory Surgery
ChiCTR2200058750Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Emergence agitation (EA), postoperative delirium (POD) and postoperative pain (3 arms), sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoints: Emergence delirium incidence and PEAD score. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)postoperative delirium (POD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200058750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058750.